February 5, 2020   Researchers identify biomarkers for selecting AMD patients for TES protocol Researchers from South Korea have validated the TES protocol through the identification of OCT-A biomarkers that correspond with recurrent sustained exudation choroidal neovascularization (CNV). Read more ADVERTISEMENT   Light-adjustable IOL technology creates novel treatment window The ability to fine-tune and customize patients' refractive outcome after cataract surgery could shift the need for physicians to do counseling and decision-making preoperatively more to postoperatively. Read more ADVERTISEMENT   Keys to assessing true crosslinking outcomes Virtual Bowman's topography software provides a new noninvasive way to look at crosslinking outcomes Read more RELATED ARTICLES   Database IDs risk factors for iris damage, dropped nucleus How to approach the out-of-pocket pricing conversation with patients Cataract surgical experiences of residents: Exploring gender differences IOP reduction after combined phaco + MIGS